Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel approaches to Neisseria meningitidis vaccine design

20 Mar 2017

Abstract excerpt

A range of vaccines is available for preventing life-threatening diseases caused by infection with Neisseria meningitidis (meningococcus, Men). Capsule polysaccharide (CPS)-conjugate vaccines are successful prophylactics for serogroup MenA, MenC, MenW and MenY infections, and outer membrane vesicle (OMV) vaccines have been used successfully for controlling clonal serogroup MenB infections. MenB vaccines based on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Infections and Vaccines
Share to Pneumonia and Respiratory Infections
Share to Respiratory viral infections research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28369428
DOI: 10.1093/femspd/ftx033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel approaches to Neisseria meningitidis vaccine designPMID 28369428Read ↗

The Development of a Vaccine Against Meningococcus B Using Reverse VaccinologySemantic proximity Read ↗

How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective<i>Neisseria meningitidis</i>VaccinesSemantic proximity Read ↗

Typing complex meningococcal vaccines to understand diversity and population structure of key vaccine antigensSemantic proximity Read ↗

A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal diseaseSemantic proximity Read ↗

Strategies for Development of Universal Vaccines Against Meningococcal Serogroup B DiseaseSemantic proximity Read ↗

Reverse vaccinology: a genome-based approach for vaccine developmentSemantic proximity Read ↗

Carbohydrate based meningococcal vaccines: past and present overviewSemantic proximity Read ↗

Bexsero® chronicleSemantic proximity Read ↗

BexseroSemantic proximity Read ↗

Pre-clinical efficacy of a candidate Outer Membrane Vesicle gonococcal vaccine in comparison with 4CMenB.Semantic proximity Read ↗

Meningococcal disease: changes in epidemiology and preventionSemantic proximity Read ↗

<i>Neisseria meningitidis</i>B vaccines: recent advances and possible immunization policiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.